News

Valneva and LimmaTech Enter into a Strategic Partnership to Accelerate the Development of the World’s Most Clinically Advanced Tetravalent Shigella Vaccine Candidate

Sandia National Laboratories acquire second Lithoz CeraFab printer to ramp up their R&D scale of additively manufactured ceramic parts

University of Vienna: The Next Generation of RNA Chips

ÖGP: Welt-Lungenkrebstag: „Zukunftsmusik“ spielt im Hier und Jetzt

MedUni Vienna: Gastric cancer - Biomarkers identified to predict the risk of relapse

MedUni Vienna: Climate change and "new" allergy triggers extend pollen season

Wiener Gesundheitsverbund und die Vinzenz Gruppe Wien setzen auf digitalen Bildaustausch

Cancer Mission Lab des Open Innovation in Science Center der LBG: Förderempfehlung für drei innovative Projekte

Pharmig: Lebenswichtig: Blutplasmaspenden werden dringend benötigt

UpNano: Novel process for 3D-printing macro-sized fused silica parts with hi-res features

Caritas Pflege: Ausschreibung für Anbieter*innen von Telemedizin/Telemedizinplattformen

MedUni Vienna: Kidney transplantation: Combined cell therapy reduces donor-specific immune response

HOOKIPA Pharma Announces Leadership Changes to Intensify Focus on HB-200

CEPI Expands Partnership with Valneva with a $41.3 Million Grant to Support Broader Access to the World’s First Chikungunya Vaccine

Nachhaltige Arzneimittelproduktion bei Takeda

Matthias Gauly zum Rektor der Veterinärmedizinischen Universität Wien gewählt

First half of 2024: Boehringer Ingelheim progresses pipeline at pace and reaches major milestones

New Partnership between Hamilton and Platomics

invIOs: We are proud to announce that invIOs has selected INV501’s lead candidate to progress into IND-enabling studies in glioblastoma and melanoma.

MADx: Präzise Allergietests für bessere Patientenbetreuung